Novel Tools for Diagnosis and Monitoring of AML

por Guijarro, Francesca, Garrote, Marta, Villamor, Neus, Colomer, Dolors, Esteve, Jordi, López-Guerra, Mónica
Publicado 2023

Challenges with Approved Targeted Therapies against Recurrent Mutations in CLL: A Place for New Actionable Targets

por López-Oreja, Irene, Playa-Albinyana, Heribert, Arenas, Fabián, López-Guerra, Mónica, Colomer, Dolors
Publicado 2021

Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing

por Garrote, Marta, López-Guerra, Mónica, Arellano-Rodrigo, Eduardo, Rozman, María, Carbonell, Sara, Guijarro, Francesca, Santaliestra, Marta, Triguero, Ana, Colomer, Dolors, Cervantes, Francisco, Álvarez-Larrán, Alberto
Publicado 2023

Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia

por Giménez, Neus, Schulz, Ralph, Higashi, Morihiro, Aymerich, Marta, Villamor, Neus, Delgado, Julio, Juan, Manel, López-Guerra, Mònica, Campo, Elias, Rosich, Laia, Seiffert, Martina, Colomer, Dolors
Publicado 2019

Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma

por Rosich, Laia, Montraveta, Arnau, Xargay-Torrent, Sílvia, López-Guerra, Mónica, Roldán, Jocabed, Aymerich, Marta, Salaverria, Itziar, Beà, Sílvia, Campo, Elías, Pérez-Galán, Patricia, Roué, Gaël, Colomer, Dolors
Publicado 2014

Bcl-2(high) mantle cell lymphoma cells are sensitized to acadesine with ABT-199

por Montraveta, Arnau, Xargay-Torrent, Sílvia, Rosich, Laia, López-Guerra, Mònica, Roldán, Jocabed, Rodríguez, Vanina, Lee-Vergés, Eriong, de Frías, Mercè, Campàs, Clara, Campo, Elias, Roué, Gaël, Colomer, Dolors
Publicado 2015

SF3B1 mutation–mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia

por López-Oreja, Irene, Gohr, André, Playa-Albinyana, Heribert, Giró, Ariadna, Arenas, Fabian, Higashi, Morihiro, Tripathi, Rupal, López-Guerra, Mònica, Irimia, Manuel, Aymerich, Marta, Valcárcel, Juan, Bonnal, Sophie, Colomer, Dolors
Publicado 2023

P1054: CLINICAL CHARACTERISTICS AND OUTCOMES IN 175 PATIENTS WITH MYELOFIBROSIS ACCORDING TO GENOMIC CLASSIFICATION USING NEXT-GENERATION SEQUENCING

por Garrote Ordeig, Marta, Lopez-Guerra, Monica, Arellano-Rodrigo, Eduardo, Rozman, Maria, Carbonell Ordeig, Sara, Guijarro, Francesca, Santaliestra Tomas, Marta, Triguero Moreno, Ana, Colomer, Dolors, Cervantes, Francisco, Alvarez Larran, Alberto
Publicado 2023

Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma

por Montraveta, Arnau, Xargay-Torrent, Sílvia, López-Guerra, Mónica, Rosich, Laia, Pérez-Galán, Patricia, Salaverria, Itziar, Beà, Silvia, Kalko, Susana G., de Frias, Mercè, Campàs, Clara, Roué, Gaël, Colomer, Dolors
Publicado 2014

The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia

por Xargay-Torrent, Sílvia, López-Guerra, Mónica, Rosich, Laia, Montraveta, Arnau, Roldán, Jocabed, Rodríguez, Vanina, Villamor, Neus, Aymerich, Marta, Lagisetti, Chandraiah, Webb, Thomas R., López-Otín, Carlos, Campo, Elias, Colomer, Dolors
Publicado 2015

P532: KINETICS AND PROGNOSTIC VALUE OF MEASURABLE RESIDUAL DISEASE (MRD) IN PATIENTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH VENETOCLAX IN COMBINATION WITH HYPOMET...

por Jimenez-Vicente, Carlos, Guijarro, Francesca, Lopez-Guerra, Monica, Guardia-Torrelles, Ares, Martínez Roca, Alexandra, Bataller, Alex, Esteban, Daniel, Cortés, Albert, Zugasti, Inés, Munarriz, Daniel, Colomer, Dolors, Diaz-Beya, Marina, Esteve, Jordi
Publicado 2023

All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia

por López-Oreja, Irene, López-Guerra, Mónica, Correa, Juan, Mozas, Pablo, Muntañola, Ana, Muñoz, Luz, Salgado, Ana-Camino, Ruiz-Gaspà, Sílvia, Costa, Dolors, Beà, Sílvia, Jares, Pedro, Campo, Elías, Colomer, Dolors, Nadeu, Ferran
Publicado 2023

Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia

por Gimenez, Neus, Tripathi, Rupal, Giró, Ariadna, Rosich, Laia, López-Guerra, Mònica, López-Oreja, Irene, Playa-Albinyana, Heribert, Arenas, Fabian, Mas, José Manuel, Pérez-Galán, Patricia, Delgado, Julio, Campo, Elias, Farrés, Judith, Colomer, Dolors
Publicado 2020

Chronic lymphocytic leukemia and prolymphocytic leukemia. Two coins or two sides of the same coin?

por Magnano, Laura, Navarro, Alba, López-Guerra, Mónica, Clot, Guillem, Beà, Sílvia, Bastidas, Gabriela, Costa, Dolors, Rivero, Andrea, Garrote, Marta, Giné, Eva, Rozman, María, Aymerich, Marta, Colomer, Dolors, López-Guillermo, Armando, Campo, Elías, Villamor, Neus, Matutes, Estella
Publicado 2020

Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy

por Silkenstedt, Elisabeth, Arenas, Fabian, Colom-Sanmartí, Berta, Xargay-Torrent, Sílvia, Higashi, Morihiro, Giró, Ariadna, Rodriguez, Vanina, Fuentes, Patricia, Aulitzky, Walter E., van der Kuip, Heiko, Beà, Sílvia, Toribio, Maria L., Campo, Elias, López-Guerra, Mònica, Colomer, Dolors
Publicado 2019

Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a S...

por Rivero, Andrea, Mozas, Pablo, Jiménez, Laura, López-Guerra, Mónica, Colomer, Dolors, Bataller, Alex, Correa, Juan, Rivas-Delgado, Alfredo, Bastidas, Gabriela, Baumann, Tycho, Martínez-Trillos, Alejandra, Delgado, Julio, Giné, Eva, Campo, Elías, López-Guillermo, Armando, Villamor, Neus, Magnano, Laura, Matutes, Estella
Publicado 2021

CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia

por Montraveta, Arnau, Lee-Vergés, Eriong, Roldán, Jocabed, Jiménez, Laura, Cabezas, Sandra, Clot, Guillem, Pinyol, Magda, Xargay-Torrent, Sílvia, Rosich, Laia, Arimany-Nardí, Cristina, Aymerich, Marta, Villamor, Neus, López-Guillermo, Armando, Pérez-Galán, Patricia, Roué, Gaël, Pastor-Anglada, Marçal, Campo, Elías, López-Guerra, Mónica, Colomer, Dolors
Publicado 2015

Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy

por Moreno, David F., Pereira, Arturo, Tovar, Natalia, Cibeira, María Teresa, Magnano, Laura, Rozman, María, López-Guerra, Mónica, Colomer, Dolors, Martín-Antonio, Beatriz, Jiménez-Segura, Raquel, Isola, Ignacio, Rodríguez-Lobato, Luis Gerardo, Oliver-Caldés, Aina, Mena, Mari Pau, Rosiñol, Laura, Bladé, Joan, Fernández de Larrea, Carlos
Publicado 2021

Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells

por López-Guerra, Mónica, Xargay-Torrent, Sílvia, Fuentes, Patricia, Roldán, Jocabed, González-Farré, Blanca, Rosich, Laia, Silkenstedt, Elisabeth, García-León, María J., Lee-Vergés, Eriong, Giménez, Neus, Giró, Ariadna, Aymerich, Marta, Villamor, Neus, Delgado, Julio, López-Guillermo, Armando, Puente, Xose S., Campo, Elias, Toribio, María L., Colomer, Dolors
Publicado 2019

Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes

por Castaño-Díez, Sandra, López-Guerra, Mónica, Bosch-Castañeda, Cristina, Bataller, Alex, Charry, Paola, Esteban, Daniel, Guijarro, Francesca, Jiménez-Vicente, Carlos, Castillo-Girón, Carlos, Cortes, Albert, Martínez-Roca, Alexandra, Triguero, Ana, Álamo, José Ramón, Beà, Silvia, Costa, Dolors, Colomer, Dolors, Rozman, María, Esteve, Jordi, Díaz-Beyá, Marina
Publicado 2022